Valuation: Terumo Corporation

Market Cap 3,263B 20.18B 17.7B 16.31B 15.27B 28.64B 1,904B 29.23B 196B 75.87B 941B 75.79B 74.13B P/E 2027 *
19.5x
P/E 2028 * 17.6x
Enterprise Value 3,339B 20.65B 18.11B 16.69B 15.63B 29.3B 1,948B 29.91B 201B 77.63B 963B 77.55B 75.85B EV / Sales 2027 *
2.7x
EV / Sales 2028 * 2.49x
Free-Float
97.07%
Yield 2027 *
1.61%
Yield 2028 * 1.8%
1 day+1.97%
1 week-1.96%
Current month-8.74%
1 month-8.44%
3 months+5.26%
6 months-6.25%
Current year-5.34%
1 week 13.07
Extreme 13.07
13.92
1 month 13.07
Extreme 13.07
15.67
Current year 12.08
Extreme 12.08
15.67
1 year 12.08
Extreme 12.08
19.6
3 years 12.08
Extreme 12.08
21.22
5 years 12.08
Extreme 12.08
25.26
10 years 8.48
Extreme 8.475
25.26
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
+1.97%-1.96% - - 20.18B
+0.94%+6.46%-29.96%-12.68% 164B
+1.48%+2.07%-5.86%-7.08% 104B
-0.29%+5.26%-4.44%+51.57% 55.67B
-2.09%-6.13%+50.84%+54.81% 52.92B
+3.00%+8.29%-8.74%-39.62% 42.96B
+2.91%+8.15% - - 32.87B
+2.17%-3.22%-18.75%-43.21% 27.07B
+1.24%+6.98%+60.30%-5.01% 24.79B
+2.41%+6.45%-9.68%-0.53% 21.02B
Average +1.37%+3.42%+4.21%-0.22% 58.32B
Weighted average by Cap. +1.07%+3.85%-5.42%-0.10%

Financials

2027 *2028 *
Net sales 1,236B 7.65B 6.71B 6.18B 5.79B 10.85B 722B 11.08B 74.3B 28.75B 357B 28.72B 28.09B 1,315B 8.13B 7.13B 6.57B 6.15B 11.54B 767B 11.78B 79B 30.57B 379B 30.54B 29.87B
Net income 166B 1.02B 898M 827M 775M 1.45B 96.58B 1.48B 9.95B 3.85B 47.73B 3.84B 3.76B 185B 1.15B 1B 926M 867M 1.63B 108B 1.66B 11.13B 4.31B 53.4B 4.3B 4.21B
Net Debt 75.69B 468M 411M 378M 354M 664M 44.17B 678M 4.55B 1.76B 21.83B 1.76B 1.72B 14.29B 88.4M 77.51M 71.44M 66.88M 125M 8.34B 128M 859M 332M 4.12B 332M 325M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
26-06-26 US$13.73 +1.97% 94,402
26-06-25 US$13.46 +0.07% 145,783
26-06-24 US$13.45 -0.37% 106,377
26-06-23 US$13.50 -2.81% 179,386
26-06-22 US$13.89 -0.79% 160,768
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,212.00JPY
Average target price
2,970.00JPY
Spread / Average Target
+34.27%

Quarterly revenue - Rate of surprise